8-22046298-G-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_003867.4(FGF17):c.250+7G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,611,804 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_003867.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGF17 | NM_003867.4 | c.250+7G>A | splice_region_variant, intron_variant | ENST00000359441.4 | NP_003858.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGF17 | ENST00000359441.4 | c.250+7G>A | splice_region_variant, intron_variant | 1 | NM_003867.4 | ENSP00000352414.3 | ||||
FGF17 | ENST00000518533.5 | c.217+7G>A | splice_region_variant, intron_variant | 1 | ENSP00000431041.1 | |||||
FGF17 | ENST00000521709.1 | n.595+7G>A | splice_region_variant, intron_variant | 3 | ||||||
FGF17 | ENST00000524314.1 | n.1620+7G>A | splice_region_variant, intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000116 AC: 29AN: 249066Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134850
GnomAD4 exome AF: 0.000147 AC: 215AN: 1459458Hom.: 1 Cov.: 33 AF XY: 0.000143 AC XY: 104AN XY: 725742
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74488
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 17, 2023 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
FGF17-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 20, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at